Giant lymph node hyperplasia (castleman's disease) with spontaneous production of high levels of b‐cell differentiation factor activity

A 13‐year‐old girl presented with general fatigue, back pain, anemia, hyperimmunoglobulinemia, and a mediastinal mass on chest radiograph. A mass was surgically removed, and its histologic examination determined the diagnosis of giant lymph node hyperplasia (Castleman's disease). With removal of the hyperplastic lymph node, the clinical symptoms soon disappeared and the abnormal laboratory findings were markedly improved within 1 month: serum IgG levels decreased from 4350 mg/dl to 1829 mg/dl. Immunostaining on the lymph node sections revealed polyclonal B‐lymphocyte and T‐lymphocyte populations. The patient's lymph node cells were cultured without any mitogenic stimulation, and the culture supernatants were assayed for their B‐cell differentiation factor (BCDF) activity to induce IgG production by our Epstein‐Barr virus‐transformed cell line. The patient's lymph node cells produced high levels of BCDF activity: the supernatants could increase the IgG production from 140 ng/ml to 410 ng/ml when the values became from 140 ng/ml to 142 ng/ml or 148 ng/ml with those of the control lymph node cells. These results suggest that the hyperimmunoglobulinemia and its prompt improvement with removal of the hyperplastic lymph node may have been related to the spontaneous production of high levels of BCDF activity by the lymph node cells in the patient.

[1]  M. Yanagisawa Analysis of Killer Cell Activities in Epstein‐Barr Virus Infections , 1987, Acta paediatrica Japonica : Overseas edition.

[2]  Y. Ueyama,et al.  Differentiation antigens defined by mouse monoclonal antibodies against human germ cell tumors. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[3]  W. Fiers,et al.  B cell growth modulating and differentiating activity of recombinant human 26‐kd protein (BSF‐2, HuIFN‐beta 2, HPGF). , 1987, The EMBO journal.

[4]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[5]  S. Akira,et al.  Effect of B cell differentiation factor (BCDF) on biosynthesis and secretion of immunoglobulin molecules in human B cell lines. , 1985, Journal of immunology.

[6]  J. D. Marshall,et al.  Novel B-cell maturation factor from spontaneously autoimmune viable motheaten mice. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[7]  V. Desmet,et al.  Distribution of lymphocyte subsets in a case of angiofollicular lymph node hyperplasia. , 1984, American journal of clinical pathology.

[8]  T. Takami,et al.  Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies. , 1984, Clinical and experimental immunology.

[9]  T. Kishimoto,et al.  Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. , 1984, Journal of immunology.

[10]  T. M. Fieser,et al.  B Cell‐Tropic Interleukins in Murine Systemic Lupus Erythematosus (SLE) 1 , 1984, Immunological reviews.

[11]  T. Kishimoto,et al.  T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. , 1981, Journal of immunology.

[12]  R. Braylan,et al.  Immunological markers and DNA content in a case of giant lymph node hyperplasia (Castleman's disease) , 1980, Cancer.

[13]  B. Dupont,et al.  Benign giant lymphoid hyperplasia of the mediastinum with associated abnormalities of the immune system. , 1974, The Journal of pediatrics.

[14]  B. Castleman,et al.  Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locations , 1972, Cancer.

[15]  B. Castleman,et al.  Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.

[16]  T. Hirano,et al.  Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  W. Paul,et al.  Regulation of B-cell growth and differentiation by soluble factors. , 1983, Annual review of immunology.

[18]  Y. Miyagawa,et al.  Demonstration of T lymphocytotoxic human fetal antibody against maternal T and concanavalin A‐inducible adult T cells in cord IgM , 1981, European journal of immunology.

[19]  K. Tung,et al.  Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature , 1967, Cancer.